beta

AZN

Astrazeneca plc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Market Cap: 202 Billion

Primary Exchange: NASDAQ

Website: https://www.astrazeneca.com/

Shares Outstanding: 3.1 Billion

Float: 0

Dividend: 1.4360315076801329 (0.02%)

Beta: 0.5250199322082872

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 1134 trading days

From: 2014-05-01 To: 2018-11-07

Lowest Point:

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

IHF: Healthcare Providers ETF - 2020 Election Anxiety

via: SeekingAlpha at 2019-06-13 03:29:05:000

The iShares U.S. Healthcare Providers ETF (NYSE: IHF ) tracks a basket of stocks with exposure to health insurance, diagnostics, specialized treatment, and healthcare industry service providers. The exchange-traded fund with an inception date in 2006 currently has over $850 million in assets… read more...

My Recession Buy List - Sweden

via: SeekingAlpha at 2019-06-12 09:06:21:000

It's no secret that once a recession hits, such as during 1999-2000, or 2009-2010, quality companies are on sale just like other companies. For many companies, one could argue that a general downturn is the only time when the company is actually undervalued, or fairly valued, barring something… read more...

Zymeworks: Leader In Bispecifics Space Makes Substantial Headway

via: SeekingAlpha at 2019-06-11 02:07:59:000

Shares of Zymeworks ( ZYME ) have nearly doubled since I suggested that readers "buy the dip" in February 2018. In that article, I pointed out that a bet on the stock was not merely a wager on prospects for lead program ZW25, but also on its impressive platform technologies with several part… read more...

FARXIGA Study Showed Reduced Progression of Kidney Disease or Renal Death in Patients with Type 2 Diabetes

via: Business Wire at 2019-06-10 04:00:00:000

FARXIGA showed a 47% reduction in the composite of kidney function decline, end-stage renal disease or renal death in a pre-specified analysis from DECLARE-TIMI 58 A pre-specified exploratory analysis of renal data from the Phase III DECLARE-TIMI 58 trial, the broadest cardiovascu… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-08-08 2019-09-09 2019-08-09 2019-07-25 0.9 Decrease
2019-02-28 2019-03-27 2019-03-01 2019-02-14 1.9 Increase
2018-08-09 2018-09-10 2018-08-10 2018-07-26 0.9 Decrease
2018-02-15 2018-03-19 2018-02-16 2018-02-02 1.9 Increase
2017-08-09 2018-09-11 2017-08-11 2017-07-27 0.9 Decrease
2017-02-15 2017-03-20 2017-02-17 2017-02-02 1.9 Increase
2016-08-10 2016-09-12 2016-08-12 2016-07-28 0.9 Decrease
2016-02-17 2016-03-21 2016-02-19 2016-02-04 1.9 Increase
2015-08-12 2015-09-14 2015-08-14 2015-07-30 0.9 Decrease
2015-02-18 2015-03-23 2015-02-20 2015-02-05 1.9 Increase
2020-02-27 2020-03-30 2020-02-28 0.95 Cash
2020-08-13 2020-09-14 2020-08-14 2020-07-30 0.45 Cash
2021-02-25 2021-03-29 2021-02-26 0.95 Cash
2021-08-12 2021-09-13 2021-08-13 0.45 Cash
2022-02-24 2022-03-28 2022-02-25 2022-02-10 0.985 Cash
2022-08-11 2022-09-12 2022-08-12 0.465 Cash
2023-02-23 2023-03-27 2023-02-24 2023-02-09 0.985 Cash
2023-08-10 2023-09-11 2023-08-11 2023-07-28 0.465 Cash
2024-02-22 2024-03-25 2024-02-23 2024-02-08 0.985 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-07-27 2015-07-22 2015-07-24 00:00:00 -0400 0.5 2.0 1.0
Data provided by IEX Cloud